Cargando…
Cardiovascular safety of celecoxib in rheumatoid arthritis and osteoarthritis patients: A systematic review and meta-analysis
OBJECTIVE: To assess the cardiovascular safety of celecoxib compared to non-selective non-steroid anti-inflammatory drugs or placebo. METHODS: We included randomized controlled trials of oral celecoxib compared with a non-selective NSAID or placebo in rheumatoid arthritis and osteoarthritis patients...
Autores principales: | Cheng, Bai-Ru, Chen, Jia-Qi, Zhang, Xiao-Wen, Gao, Qin-Yang, Li, Wei-Hong, Yan, Li-Jiao, Zhang, Yu-Qiao, Wu, Chang-Jiang, Xing, Jing-Li, Liu, Jian-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691614/ https://www.ncbi.nlm.nih.gov/pubmed/34932581 http://dx.doi.org/10.1371/journal.pone.0261239 |
Ejemplares similares
-
Effectiveness and safety of Glucosamine, chondroitin, the two in combination, or celecoxib in the treatment of osteoarthritis of the knee
por: Zeng, Chao, et al.
Publicado: (2015) -
The cardiovascular risk of celecoxib for knee osteoarthritis: A protocol for systematic review and meta-analysis
por: Cheng, Shirui, et al.
Publicado: (2020) -
Gastrointestinal safety of etoricoxib in osteoarthritis and rheumatoid arthritis: A meta-analysis
por: Feng, Xiaoting, et al.
Publicado: (2018) -
Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT)
por: MacDonald, Thomas M, et al.
Publicado: (2013) -
Cardiovascular Safety of Celecoxib on Top of Dual Antiplatelet Therapy
por: Hong, Bum-Kee
Publicado: (2010)